Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: Additional evidence

Pharmacopsychiatry

Volumn 39, Issue 1, 2006, Pages 30-34

  Soyka, M ^a   Schmidt, F ^a,b   Schmidt, P ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Klientenzentrierte Problemberatung Dachau ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBAMAZEPINE; GAMMA GLUTAMYLTRANSFERASE; TIAPRIDE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALLERGIC REACTION; ARTICLE; ATAXIA; CONTROLLED STUDY; DELIRIUM TREMENS; DETOXIFICATION; DRUG TOLERABILITY; FEMALE; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; OUTPATIENT CARE; PRIORITY JOURNAL; PRURITUS; SCREENING; SEDATION; SIDE EFFECT; SYMPTOMATOLOGY; VERTIGO;

ADULT; ALCOHOL DRINKING; ALCOHOL WITHDRAWAL DELIRIUM; ALCOHOLISM; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE WITHDRAWAL SYNDROME; TIAPRIDE;

EID: 32544441146     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-931479     Document Type: Article

References (56)

1. Agricola R, Mazzarino M, Urani R. Treatment of acute alcohol withdrawal syndrome with carbamazepine: A double blind comparison with tiapride. J Intern Med Res 1982; 10: 160-165
2. Albani F, Riva R, Baruzzi A. Carbamazepine clinical pharmacology: a review. Pharmacopsychiatry 1995; 28: 235-244
3. Allain H, Dauzenberg PH, Maurer K, Schuck S, Bonhomme D, Gerard D. Double blind study of tiapride versus haloperidol and placebo agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology 2000; 148: 361-366
4. Alterman AI, Bedrick J, Cacciola JS et al. Personality pathology and drinking in young men at high and low familail risk for alcoholism. J Stud Alcohol 1998; 59: 495-502
5. Bjorkquist SE, Isohanni M, Makela R et al. Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre double-blind comparison with placebo. Acta Psychiatr Scand 1976; 53: 333-342
6. Blundell RD. Ambulatory Detoxification of patients with Alcohol Dependence. Am Fam Physician 2005; 71: 495-502
7. Bonnet U, Ranger M, Leweke FM, Maschie M, Kowalski T, Gastpar M. Treatment of Alcohol Withdrawal Syndrome with Gabapentin. Pharmacopsychiatry 1999; 32: 107-109
8. Collins MN, Burns T, Van den Berk PAH, Tubman GF. A structured Programme for Out-patient Alcohol Detoxification. Br J Psychiatry 1990; 56: 871-874
9. Croissant B, Scherle T, Diehl A, Heinz A, Mann K. Oxcarbazepine in Alcohol Relapse Prevention. Pharmacopsychiatry 2004; 37: 306-307
10. Feldman DJ, Pattison EM, Sobell LC et al. Out-Patient alcohol detoxification: initial findings on 564 patients. Am J Psychiatry 1975; 132: 407-412
11. Flygenring J, Hansen J, Holst B, Petersen E, Sorensen A. Treatment of alcohol withdrawal symptoms in hospitalized patients. A randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal). Acta Psychiatr Scand 1984; 69: 398-408
12. Franz M, Dlabal H, Kunz S, Ulferts J, Gruppe H, Gallhofer B. Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. Eur Arch Psychiatry Clin Neurosci 2001; 251: 185-192
13. Gartenmeier A, Pelzer E, Soyka M. Treatment of alcohol withdrawal syndrome with combined carbamazepine and tiapride in a patient with probable sleep apnoea syndrome. Pharmacopsychiatry 2005; 3: 96-98
14. Gottesleben A, Willemsen D, Wolf C. Retardiertes Carbamazepin in der Therapie des alkoholischen Prädelirs. Akt Neurol 1995; 22: 60-65
15. Hayashida M, Alterman AI, McLellan T et al. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med 1989; 320: 358-365
16. Johnson BA. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Expert Opin Pharmacotherapy 2004; 5: 1943-1955
17. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ. Oral topiramate for treatment of alcohol dependence: a randomized controlled trial. Lancet 2003; 361: 1677-1685
18. R). An Open-Label trial (in German). Krankenhauspsychiatrie 2004; 15: 114-116
19. Lepola U, Kokko S, Nuutila J, Gordin A. Tiapride and chlordiazepoxide in acute alcohol withdrawal. A controlled clinical trial. International J Clin Pharm Res 1984; 5: 321-326
20. Lucht MJ, Kuehn KU, Schroeder W, Armbruster J, Abraham G, Schattenberg A, Gaensicke M, Barnow S, Tretzel H, Herrmann FH, Freyberger HJ. Influence of the dopamine D2 receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawal. Pharmacogenetics 2001; 11: 647-653
21. Lucht M, Kuehn KU, Armbruster J, Abraham G, Gaensicke M, Barnow S, Tretzel H, Freyberger HJ. Alcohol withdrawal Treatment in intoxicated Vs Non-Intoxicated patients: A controlled open-label Study with Tiapride/Carbamazepine, Clomethiazole and Diazepam. Alcohol Alcohol 2003; 38: 168-175
22. Majumdar SK. Chlomethiazole: Current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 1990; 27: 201-207
23. Malcolm R, Myrick H, Brady KT, Ballenger JC. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 2001; 10 (Suppl.): 16-23
24. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 2002; 17: 349-355
25. Malcolm R, Ballenger JC, Sturgis ET, Anton RA. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146: 617-621
26. Mariani JJ, Levin FR. Pharmacotherapy for Alcohol-Related Disorders: What Clinicians Should Know. Harv Rev Psychiatry 2004; 23: 351-366
27. Mayo-Smith MF for the American Society of Addiction Medicine, Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological Management of Alcohol Withdrawal. A Meta-analysis and Evidence-Based Practice Guideline. JAMA 1997; 278: 144-151
28. Mayo-Smith MF, Beecher LH, Fischer TL, Gorekick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J. Management of Alcohol Withdrawal Delirium. An Evidence-Based Guideline. Arch Intern Med 2004; 164: 1405-1412
29. Mueller TI, Stout RL, Rudden S, Brown RA, Gordon A, Dolomon DA, Recupero PR. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res 1997; 21: 86-92
30. Murphy DJ, Shaw GK, Clarke I. Tiapride and chlormethiazole in alcohol withdrawal: a double-blind trial. Alcohol Alcohol 1983; 18: 227-237
31. O'Connor PG, Gottlieb LD, Kraus ML, Segal SR, Horwitz RI. Social and clinical features as predictors of outcome in outpatient alcohol withdrawal. J Gen Intern Med 1991; 6: 312-316
32. Palsson A. The efficacy of early chlormethiazole medication in the prevention of delirium tremens. A retrospective study of the outcome of different drug treatment strategies at the Helsingborg psychiatric clinics, 1975-1980. Acta Psychiatr Scand 1986; 73 (Suppl. 329): 140-145
33. Peters DH, Faulds D. Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs 1994; 47: 1010-1032
34. Ritola E, Malinen L. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981; 64: 254-259
35. Robert PH, Allain H. Clinical management of agitation in the elderly with tiapride. Eur Psychiatry 2001; 16: 42s-47
36. Rubio G, Ponce G, Jime'nez-Arriero MA, Palomo T, Manzanares J, Ferre F. Effects of Topiramate in the Treatment of Alcohol Dependence. Pharmacopsychiatry 2004; 37: 37-40
37. Scatton B, Cohen C, Perrault G, Oblin A, Claustre Y, Schoemaker H, Sanger DJ, Rouquier L, Porsolt R. The preclinical pharmacologic profile of tiapride. Eur Psychiatry 2001; 16: 29s-34
38. Seifert J, Peters E, Kahn K, Metzner C, Ohlmeier M, Te Wildt B, Emrich HM, Schneider U. Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance - a pilot study. Addict Biol 2004; 9: 43-51
39. Shaw GK, Majumdar SK, Waller S, MacGarvie J, Dunn G. Tiapride in the long-term management of alcoholics of anxious or depressive treatment. Br J Psychiatry 1987; 150: 164-168
40. Shaw GK, Waller S, Majumdar SK, Alberts JL, Latham CJ, Dunn G. Tiapride in the prevention of relapse in recently detoxified alcoholics. Br J Psychiatry 1994; 165: 515-523
41. Soyka M, Morhart-Klute V, Horak M. A combination of carbamazepine/ tiapride in outpatient alcohol detoxification. Results from an open clinical study. Eur Arch Psychiatry Clin Neurosci 2002; 252: 197-200
42. Soyka M, Horak M, Löhnert B, Löhnert E, Rüster P, Möller HJ. Ambulante Entgiftung Alkoholabhängiger - Ein Modellversuch. Nervenheilkunde 1999; 8: 147-152
43. Soyka M, Clausius N, Hohendorf G, Horak M. Outpatient detxofication with carbamazepine and tiparide - medical safety and results of a follow-up study (in German). Suchtmed 2004; 6: 307-311
44. Stinnett JL. Outpatient detoxification of the alcoholic. Int J Addict 1982; 17: 1031-1046
45. Stockwell T, Bolt E, Hooper J. Detoxification from alcohol at home managed by general practitioners. Br Med J 1986; 292: 733-735
46. Stuppaeck CH, Barnas C, Hackenberg K, Miller CH, Fleischhacker WW. Carbamazepine monotherapy in the treatment of alcohol withdrawal. Int Clin Psychopharmacol 1990; 5: 273-278
47. Stuppaeck CH, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Whitworth AB, Fleischhacker WW. Assessment of the alcohol withdrawal syndrome-validity and reliability of the translated and modified clinical institute withdrawal assessment for alcohol scale (CIWA-A). Addiction 1994; 89: 1287-1292
48. Stuppaeck C, Pycha R, Miller C, Whitworth A, Oberbauer H, Fleischhacker W. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol 1992; 27: 153-158
49. Sullivan JT, Sykora K, Schneiderman J, Neranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal scale (CIWA-Ar). Br J Addict 1989; 84: 1353-1357
50. Thome J, Wiesbeck GA, Vince GH. Carbamazepin in der Behandlung des Alkoholentzugssyndroms - Eine Übersicht zum aktuellen Forschungsstand. Fortschr Neurol Psychiat 1994; 62: 125-133
51. Webb M, Unwin A. The outcome of outpatient withdrawal from alcohol. Br J Addict 1988; 83: 929-934
52. Whitfield CL, Thompson G, Lamb A, Spencer v, Pfeifer M, Browning-Ferrando M. Detoxification of 1,024 alcoholic patients without psychoactive drugs. JAMA 1978; 239: 1409-1410
53. WHO. Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F) Forschungskriterien. Dilling H, Mombour W, Schmidt MH, Schulte-Warkwort E, eds. Huber, Bern: 1994
54. Williams D, BcBride AJ. The drug treatment of alcohol withdrawal symptoms: a systematic review. Alcohol Alcohol 1998; 33: 103-115
55. Wiseman EJ, Henderson KL, Briggs MJ. Individualized treatment for outpatients withdrawing from alcohol. J Clin Psychiatry 1998; 59: 289-293
56. Wojnar M, Bizon Z, Wasilweski D. The role of somatic disorders and physical injury in the development and course of alcohol withdrawal delirium. Alcohol Clin Exp Res 1999; 23: 209-213